Alberto Bardelli

Full Professor, Department of Oncology - University of Torino Scientific Director, IFOM ETS – The AIRC Institute of Molecular Oncology https://www.ifom.eu/en/ http://biotec.campusnet.unito.it/do/docenti.pl/Show?_id=albardel;sort=DEFAULT;search=;hits=76 H Index: Google Scholar 103; Scopus 93 Bardelli has authored more than 250 peer-reviewed papers in international journals. Work Experience 2022-pres. Scientific Director, IFOM ETS – The AIRC Institute of Molecular Oncology 2016-pres. Full Professor, University of Torino, School of Medicine. 2004-pres. Director, Laboratory of Molecular Oncology Education and training 1991-1996 PhD degree in Biochemistry and Molecular Biology, University College London. Supervisor: Prof. M. Waterfield 1991 Master Degree in Biological Sciences, University of Torino, Italy, 110/110 cum laude. Licensure and Certification 1995-1999 Specialization in Clinical Pathology, University of Torino, School of Medicine Previous positions 1999-2004 Postdoctoral fellow, The Johns Hopkins University; Baltimore MD USA. Supervisor: Prof. Bert Vogelstein. 1996-1999 Postdoctoral Fellow, IRCC and the University of Torino, School of Medicine Fellowships, awards and academy memberships 2021 ERC Advanced Grant 2020 Guido Venosta Award, FIRC AIRC, Presidenza della Repubblica Italiana 2019 Member of the Johns Hopkins Society of Scholars 2018-2020 Highly Cited Researcher, Web of Science, Claryvate 2017 European Society for Medical Oncology (ESMO) Translational Research Award 2017 Fellow of European Molecular Biology Organization (EMBO) 2016 Grant for Oncology Innovation Research Project 2015 Fellow of the European Academy of Cancer Sciences 2015 Fellow of the Turin Academy of Sciences 2014 Thomson Reuters Highly Cited Researcher - Beautiful Minds List 2004 The Alfred Blalock Research Award - Johns Hopkins Medical School, Baltimore USA 1999-2004 Fellowship, Howard Hughes Medical Institute, Baltimore MD USA 1996 Cecilia Cioffrese -Cancer Research Award, Carlo Erba Foundation 1994 Francesca e Ferdinando Quartero, Cancer Research Prize, Italian Cancer Association 1994 VIII Mascia Brunelli-Award, Italian Cell Culture Association 1991 Graduated with Honor and Distinction (Laude, Menzione d’Onore), University of Torino Editorial Boards 2019-pres. Editorial Board member, Genome Medicine 2017-pres. Editorial Board member, Nature Reviews Clinical Oncology 2016-pres. Editorial Board member, Cancer Discovery 2 2014-pres. Editorial Board member, Molecular Oncology 2014-pres. Editorial Board member, Clinical Cancer Drugs 2013-pres. Editorial Board member, Cancer Treatment Reviews 2011-pres. Editorial Board member, BMC Gastroenterology 2010-pres. Executive Editors, Molecular Cancer 2007-pres. Editorial Board member, International Journal of Oncology Reviewer Science, Nature, Cancer Cell, Cancer Discovery, Cancer Research, Clinical Cancer Research, Science Signaling, Nature Medicine, The EMBO Journal, Proceedings Of The National Academy Of Sciences (PNAS), The Journal of Clinical Investigation, NEJM, Nature Cancer. Commissions of trust 2021-pres. Scientific Advisory Board member, Oncode Institute, Utrecht (The Netherlands) 2019-pres. The Johns Hopkins Society of Scholars, Baltimore (USA) 2018-pres. Scientific Advisory Board member, MD Anderson Moon Shots Program, Houston (USA) 2018-pres. Scientific Advisory Board member, Neophore, Cambridge (UK) 2018-2020 President, EACR (European Association for Cancer Research) 2017-pres. Scientific Advisory Board member, Cancer Research UK Manchester Institute, Manchester (UK) 2015-pres. Board Member, European Association for Cancer Research (EACR) 2013-pres. Scientific Committee, Pezcoller Foundation 2013-pres. Scientific Committee, AIRC (Italian Association for Cancer Research) 2012-pres. Director, Basic Research, Candiolo Cancer Institute, Candiolo (To), Italy 2008-pres. Scientific Advisory Board member, Horizon Discovery, Cambridge (UK) Publications Book chapter: Y. Samuels-A. Bardelli – C. Lopetz Otin, The Cancer Genome, in DeVita-Hellman-Rosenberg, Cancer: Principles and Practice of Oncology, Lippincott Williams & Wilkins, Philadelphia, 2011